Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2(1H)-pyridinethionato-kappaS2)[2,6-bis[(mercapto-KappaS)methyl]pyridine-kappaN1] oxorhenium(V)
-
-
(methanethiolato)[2,2'-(thio-kappaS)bis[ethanethiolato-kappaS]] oxorhenium (V)
-
-
(p-methoxyphenylthiolato-S)[2,6-bis[(mercapto-kappaS)methyl]pyridine-kappaN] oxorhenium(V)
-
-
2-aminobenzoyl-KLRGSKQ-(N-(ethylenediamine)-2,4-dinitrophenyl amide)
-
-
2-phenyl-1H-indole-3-carbaldehyde thiosemicarbazone
-
a thiosemicarbazon
3-[(1H-benzimidazol-2-yl)-2H-1-benzopyran-2-ylidene]-2-carbaldehyde semicarbazone
-
a semicarbazone
4-(cyclohexylamino)-6-[(2-methoxy-3-pyridinyl)amino]-1,3,5-triazine-2-carbonitrile
-
a nitrile
4-methyl N-[(S)-1-oxo-1-[(S)-1-oxo-4-phenyl-1-(5-phenylisoxazol-3-yl)butan-2-ylamino]-3-phenylpropan-2-yl]piperazine-1-carboxamide
-
-
5-(4-methoxy-phenyl)-2-furanyl-2-carbaldehyde thiosemicarbazone
-
a thiosemicarbazon
aceto[2,6-bis[(butylthio-jS)methyl]phenyl-kappaC]-,(SP-4-3)-palladium(II)
-
-
benzoyl-(4-aminomethyl-cyclohexyl-alanine)-R-4-methylcoumarin-7-amide
-
-
cathepsin L inhibitor IV
-
-
-
chloro[2,2'-(thio-kappaS)bis[ethanethiolato-kappaS]] oxorhenium(V)
-
-
cystatin
-
1 microM, 37°C, 48 h, pH 5.0
-
diaceto[2-[(2-pyridinyl-kappaN)methyl]-phenyl-kappaC]Au(III)-,(SP-4-3)
-
-
FAARYLNGAQ-[N-(2,4-dinitrophenyl)]-ethylenediamine
-
-
N-((S)-1-[(S)-1-[1-(benzyloxymethyl)-1H-1,2,3-triazol-4-yl]-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl)morpholine-4-carboxamide
-
-
N-[(2S)-1-[(2S)-1-hydroxy-3-phenyl-1-(5-phenyl-1,2,4-oxadiazol-3-yl)propan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(1-phenyl-1H-1,2,3-triazol-4-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(3-phenylisoxazol-5-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylisoxazol-3-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenyloxazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylthiazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-[(d)-1-(5-benzylisoxazol-3-yl)-1-oxo-4-phenylbutan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-[(S)-1-(benzo[d]oxazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[(S)-1-[(S)-1-(benzo[d]thiazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide
-
-
N-[1-(4'-chloro-5-hydroxy-3-oxo[1,2,3,6-tetrahydro[1,1'-biphenyl]]-4-yl)-1-oxopropan-2-yl]benzamide
drug-like, non-mutagen, non-carcinogen, and non-neurotoxic lead candidate
NaCl
-
inhibition of rCPB2.8 and rCPB3 at pH higher than 5
Nalpha-(morpholin-4-ylcarbonyl)-N-[(1E,3S)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl]-L-phenylalaninamide
-
-
Nalpha-(morpholin-4-ylcarbonyl)-N-[(2S)-1-oxo-4-phenyl-1-(5-phenyl-1,2-oxazol-3-yl)butan-2-yl]-L-phenylalaninamide
-
-
Nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(1E,3S)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl]-L-phenylalaninamide
-
-
o-aminobenzoyl-FAARYLNGA-NH2
-
-
o-aminobenzoyl-FAARYLNGAQ-[N-(2,4-dinitrophenyl)]-ethylenediamine
-
-
o-aminobenzoyl-KLAFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLFFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLGFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLIFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLLFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLMFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLMFSKQ-[N-(2,4-dinitrophenyl)-ethylenediamine]
-
-
o-aminobenzoyl-KLNFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLPFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLQFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLRFSFQ-[N-(2,4-dinitrophenyl)-ethylenediamine]
-
-
o-aminobenzoyl-KLRFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLRPSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLS(OBzl)FSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLSFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLSKYLSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLSKYLSKQ-[N-(2,4-dinitrophenyl)-ethylenediamine]
-
-
o-aminobenzoyl-KLTFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLVFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLWFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-KLYFSKQ-(N-(2,4-dinitrophenyl)-ethylenediamine)
-
-
o-aminobenzoyl-LKLLRKMQ-(N-[2,4-dinitrophenyl]-ethylenediamine)
-
-
o-aminobenzoyl-LKLLRKMQ-[N-(2,4-dinitrophenyl)-ethylenediamine]
-
-
o-aminobenzoyl-MISLMKRPQ-[N-(2,4-dinitrophenyl)]-ethylenediamine
-
-
o-aminobenzoyl-RIIRIKRQ-(N-[2,4-dinitrophenyl]-ethylenediamine)
-
-
o-aminobenzoyl-RIIRIKRQ-[N-(2,4-dinitrophenyl)-ethylenediamine]
-
-
o-aminobenzoyl-YRFFRNRFQ-(N-[2,4-dinitrophenyl]-ethylenediamine)
-
-
o-aminobenzoyl-YRFFRNRFQ-[N-(2,4-dinitrophenyl)-ethylenediamine]
-
-
trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
-
1 microM, 37°C, 48 h, pH 5.0
trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane
[2-hydroxy-4-(2-methylpropoxy)phenyl](4-hydroxyphenyl)methanone
compound shows inhibitory activity against papain is a potent inhibitor of CPB2.8, CPB3.0 and cruzain, showing noncompetitive inhibition mechanism
leupeptin
-
1 microM
leupeptin
-
effective inhibitor of the recombinant mature CPB2.8DELTACTE
leupeptin
-
1 microM, 37°C, 48 h, pH 5.0
trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane
-
1 microM
trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane
-
1 microM
additional information
not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
-
additional information
not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
-
additional information
not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
-
additional information
-
not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane; not inhibitory: Z-Phe-Phe-fluoromethyl ketone and trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane
-
additional information
-
high throughput screening of a compound library, identification of inhibitors containing the warhead-types semicarbazone, thiosemicarbazone and triazine nitrile, that can be used as leads for antiparasite drug design, docking study, overview
-
additional information
benzo[b]thiophenes act immediately as noncovalent inhibitors and then as irreversible covalent inhibitors, whereas a reversible covalent mechanism emerges for the 1,3,3'-triketones with a Y-topology
-